4//SEC Filing
Golembiewski Michael Joseph 4
Accession 0001104659-23-040289
CIK 0001017491other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 5:06 PM ET
Size
8.0 KB
Accession
0001104659-23-040289
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-03-30+677,701→ 677,701 totalExercise: $0.69Exp: 2033-03-30→ Common Stock (677,701 underlying) - Award
Stock Option (right to buy)
2023-03-30+88,030→ 88,030 totalExercise: $0.69From: 2023-03-30Exp: 2033-03-30→ Common Stock (88,030 underlying)
Footnotes (2)
- [F1]1/4th of the shares subject to the option shall vest on March 30, 2024, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.
- [F2]The Reporting Person voluntarily elected to be paid 35% of his 2022 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer.
Documents
Issuer
SEELOS THERAPEUTICS, INC.
CIK 0001017491
Entity typeother
Related Parties
1- filerCIK 0001639479
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 5:06 PM ET
- Size
- 8.0 KB